WallStreetZenWallStreetZen

NASDAQ: PMCB
Pharmacyte Biotech Revenue

OverviewEarningsRevenue
DividendOwnership
Pharmacyte Biotech revenue was $0.00 for the trailing 12 months ending Apr 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Apr 30, 2026 was $0.0, down N/A from last quarter. For the last reported fiscal year 2026 ending Apr 30, 2026, PMCB annual revenue was $0.0, with N/A growth year-over-year.

PMCB revenue history

Current Revenue
$0.0
Current Earnings
-$23.2M
Current Profit Margin
0%

Be the first to know when PMCB announces revenue.

PMCB Revenue History By Year

PMCB Yearly RevenuePMCB RevenuePMCB ChangePMCB Revenue Growth
2026-04-30$0.00N/AN/A
2025-04-30$0.00N/AN/A
2024-04-30$0.00N/AN/A
2023-04-30$0.00N/AN/A
2022-04-30$0.00N/AN/A
2021-04-30$0.00N/AN/A
2020-04-30$0.00N/AN/A
2019-04-30$0.00N/AN/A
2018-04-30$0.00N/AN/A
2017-04-30$0.00N/AN/A
2016-04-30$0.00N/AN/A
2015-04-30$0.00N/AN/A
2014-04-30$0.00-$12.16k-100.00%
2013-04-30$12.16k-$54.40k-81.73%
2012-04-30$66.56k-$59.44k-47.17%
2011-04-30$126.00k-$136.94k-52.08%
2010-04-30$262.93k-$390.20k-59.74%
2009-04-30$653.13k-$536.82k-45.11%
2008-04-30$1.19MN/AN/A

1 of 2

Pharmacyte Biotech Revenue FAQ

What was PMCB's revenue last quarter?

On Mar 17, 2026, Pharmacyte Biotech (NASDAQ: PMCB) reported Q1 2026 revenue of $0.00 up N/A year over year. In the same quarter last year, Pharmacyte Biotech's revenue was $0.00.

What was Pharmacyte Biotech's revenue in 2026?

Pharmacyte Biotech's annual revenue for the twelve months ending Apr 30, 2026 was $0.00, a N/A decrease year over year.

How much does Pharmacyte Biotech make in a day?

Based on Pharmacyte Biotech annual revenue for the past five years, PMCB makes an average of $0.00 per day.

What was Pharmacyte Biotech's annual revenue growth in the past year?

As of Q3 2026, Pharmacyte Biotech's revenue has grown null year over year. Pharmacyte Biotech's revenue in the past year totaled $0.00.

How much does Pharmacyte Biotech make in a year?

Pharmacyte Biotech's revenue by year for the past five years is:
  • Pharmacyte Biotech's revenue for the twelve months ending Apr 30, 2026 was $0.00, a N/A decrease year over year.
  • Pharmacyte Biotech's annual revenue for Apr 30, 2025 was $0.00, a N/A decrease from 2024.
  • Pharmacyte Biotech's annual revenue for 2024 was $0.00, a N/A decrease from 2023.
  • Pharmacyte Biotech's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Pharmacyte Biotech's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.